NasdaqGS:DXCMMedical Equipment
DexCom Expands Stelo AI Features As Consumer Glucose Strategy Evolves
DexCom (NasdaqGS:DXCM) is rolling out new AI-enabled features for Stelo, its over-the-counter glucose biosensor.
The update adds expanded Smart Food Logging and a broad nutrition database to help users link meals with glucose responses.
The launch targets consumers interested in managing glucose health beyond traditional medical device use.
DexCom, trading at $65.08, is adding these AI-driven tools to Stelo at a time when its share price has seen pressure, with a 1-year return of a 22.6%...